Table 1: Summary of previous research on methods to identify asthma cases from administrative data
Author |
Data Source
|
Diagnosis/Treatment Codes and Algorithms |
Study Cohort |
Validation Methodology |
Comments |
Erzen et al. (1995) |
Country: Canada
Source: Physician claims from Manitoba Health
Years: 1983 and 1988
|
Codes: ICD-9-CM 493
Algorithm: One or more contacts in physician billing claims. |
All ages were examined and then grouped as follows: 0-14 years, 15-34 years, 35+ years
|
There was no validation data source. Specificity, sensitivity and predictive values are not reported.
|
|
Morrison et al. (2001) |
Country: Scotland , UK
Source: Scottish Morbidity Records
Years: 1981-1997
|
Codes: ICD-9 493 ICD-10 J45, J46
Algorithm: A patient’s first admission for asthma was labelled as the first admission; all subsequent admissions were labelled as readmissions. |
Age of cohort was not specified. |
There was no validation data source. Specificity, sensitivity and predictive values are not reported.
|
|
Huzel et al. (2002) |
Country: Canada
Source: Physician billing claims from Manitoba Health
Years: 1993-1994
|
Codes: ICD-9 493
Algorithm: One or more contacts in physician billing claims |
20 to 44 years of age |
Survey data
Max Sens = 70.1% Max Spec = 99.8% Max κ = 0.62 |
“Even if five years of physician contacts were studied, the claims identified only 63.3% of people reporting an asthma attack in the 12 months before the survey, 65.1% of people reporting being on medication, 62.0% of those reporting either an attack or using medication , and 70.1% of those reporting both an attack and using medication.” p.410 |
Hansell et al. (2003) |
Country: England
Source: Mortality data from the Office for National Statistics (ONS; 1991-1995). Hospital Episode Statistics (HES) from the Dept. of Health (1990/91 to 1993/94) and from the Data Science UK (1994/95). General Practice Research Database (GPRD; 1991-1995) |
Codes: ICD-9 493
Algorithms: From HES, emergency hospital admissions with the ICD-9 code as a primary diagnosis were abstracted. From GPRD, patients who consulted in primary care with an inhaler prescription during the current year plus a current or prior diagnosis of asthma in each year from 1991-1995 were identified.
|
Survey included ages 2 years and above. |
Health Survey of England , 1995.
Specificity, sensitivity and predictive values are not reported.
|
“There was little consistency in patterns for asthma from the different data source.” p. 281
|
Kozyrskyj et al. (2004) |
Country: Canada
Source: Hospital separations, physician billing claims, prescription drug records from Manitoba Health.
Years: 1995-1998 |
Codes: ICD-9 493
Algorithms: At least one physician claim or hospitalization for asthma-like diagnoses in one year. In the absence of these diagnoses, at least one prescription for an inhaled corticosteroid or cromone, or ketotifen concomitant with an inhaled or oral beta-agonist, or two or more prescription for an inhaled or oral beta-agonist. |
Ages 5-15 years |
A prescription for an asthma drug was used as the gold standard.
Max Sens = 73.9% Max Spec = 91.4% |
|
Borzecki et al. (2004) |
Country: USA
Source: Out-patient clinic (OPC) file for 1998 and 1999, and patient treatment file (1999), from a National Department of Veterans Affairs electronic database.
|
Codes: ICD-9 chronic obstructive lung disease/asthma 490.x, 491.x (all except for 491.8), 492.0, 493.x, 496.x
Algorithms: Varied the minimum required number of claims with a given diagnosis from 1 to 2 and varied the number of years of data from 1 to 2. |
Outpatients receiving primary care at 10 different sites across the country. |
Electronic clinicians’ notes (i.e., medical outpatient charts).
Max. Spec = 92% Max. Sens = 81% Max κ = 0.68 |
|
Wilchesky et al. (2004) |
Country: Canada
Source: Medical claims from Quebec
Year: 1995-1996 |
Codes: ICD-9-CM 493.0-493.9
Algorithm: One or more medical claims with the relevant ICD-9-CM code |
66 years of age and older |
Physicians’ charts
Max Sens = 43% Max Spec = 99% |
|
Macy et al. (2005) |
Country: USA
Source: Southern California Kaiser Permante hospital, outpatient, and prescription data
Year: 2001
|
Codes: ICD-9-CM 493.xx Drug codes were not specified, but included β-agonists (excluding oral terbutaline), orally inhaled corticosteroids, other inhaled anti-inflammatory drugs, and oral leukotriene modifiers. Algorithm: Any discharge diagnosis of asthma in the hospitalization database; or two or more asthma-related medication dispensations in the prescription database; or any ED or regular clinic asthma-related claim in the outpatient diagnosis and procedures database. |
18-64 years |
Medical chart review and questionnaire/ examinations.
Specificity, sensitivity and predictive values are not reported.
|
|
Schatz et al. (2005) |
Country: USA
Source: Southern California Kaiser-Permanente asthma database (linked hospital discharge database, outpatient diagnosis and procedures database, a membership database, and a prescription database)
Year: 2002-2003
|
Codes: ICD-9 493.xx
Algorithms: One or more of the following criteria in the prior 12 months: 1) Any hospital discharge diagnosis of asthma in the hospitalization database (ICD code), 2) the dispensing of two or more asthma-related dispensings (excluding oral steroids), including β-agonists, inhaled steroids, other inhaled anti-inflammatory drugs, and oral leukotriene modifiers, 3) an asthma related visit to the ED or regular clinic listed in the diagnosis and procedures database |
Ages 5-56 |
No validation source was used
Specificity, sensitivity and PPV are not calculated.
|
|